Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/27/2012 | CA2452836C Meningococcus adhesins nada, app and orf 40 |
11/27/2012 | CA2432525C Streptococcus pyogenes antigens and corresponding dna fragments |
11/27/2012 | CA2422057C Dipeptidyl peptidase i crystal structure and its uses |
11/27/2012 | CA2416545C Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
11/27/2012 | CA2413151C Host cells containing multiple integrating vectors |
11/27/2012 | CA2404857C Signal transduction stress-related proteins and methods of use in plants |
11/27/2012 | CA2385763C Plant seed endosperm-specific promoter |
11/27/2012 | CA2347131C Modified peptides as therapeutic agents |
11/27/2012 | CA2325605C Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein said peptides bind to mhc class i and mhc class ii molecules, and uses thereof |
11/27/2012 | CA2181832C Immunization by inoculation of dna transcription unit |
11/26/2012 | CA2778010A1 A novel blood substitute with complete red blood cell functions |
11/22/2012 | WO2012158613A1 Pre-fusion rsv f antigens |
11/22/2012 | WO2012158529A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii |
11/22/2012 | WO2012158016A1 A method for regulating biosynthesis of monolignols |
11/22/2012 | WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases |
11/22/2012 | WO2012157408A1 Cytotoxic t cell inducer |
11/22/2012 | WO2012157136A1 Rrecombinant human saposin b protein containing phosphorylated glucose ring and use thereof |
11/22/2012 | WO2012156865A1 Plants having one or more enhanced yield- related traits and method for making the same |
11/22/2012 | WO2012156760A1 Process for modifying the architecture and improving the yield of crop plants |
11/22/2012 | WO2012156747A1 Method |
11/22/2012 | WO2012156356A1 A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii |
11/22/2012 | WO2012156354A1 Spbranched1a of solanum pennellii and tomato plants with reduced branching comprising this heterologous spbranched1a gene |
11/22/2012 | WO2012156330A1 Rbm3 in bladder cancer |
11/22/2012 | WO2012156310A1 Novel peptides |
11/22/2012 | WO2012156086A1 Methods for improving and managing nucleoside reverse-transcriptase inhibition based treatment |
11/22/2012 | WO2012156083A1 Methods using transformed yeast cells for improving and managing nucleoside reverse-transcriptase inhibition based treatment |
11/22/2012 | WO2012155780A1 Branched-peg modified glp-1 analogue and pharmaceutically acceptable salts thereof |
11/22/2012 | WO2012155262A1 Virus-like particles and process for preparing same |
11/22/2012 | WO2012155256A1 Production of soluble soy protein product ("s704") |
11/22/2012 | WO2012135501A3 Axmi232, axmi233, and axmi249 toxin genes and methods for their use |
11/22/2012 | WO2012125720A3 Polypeptides having immunoactivating activity and methods of producing the same |
11/22/2012 | WO2012125445A3 Small molecule-dependent inteins and uses thereof |
11/22/2012 | WO2012118559A3 Tetravalent and mixed head bivalent dengue vaccine |
11/22/2012 | WO2012115474A3 Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same |
11/22/2012 | WO2012109538A3 Surrogates of post-translationally modified proteins and uses thereof |
11/22/2012 | WO2012094529A3 Genes implicated in resistance to soybean cyst nematode infection and methods of their use |
11/22/2012 | WO2012038953A3 Fgf-18 truncated variants having increased receptor specificity and uses thereof |
11/22/2012 | US20120297507 Method |
11/22/2012 | US20120297504 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency |
11/22/2012 | US20120297503 Novel Bacillus thuringiensis Gene with Lepidopteran Activity |
11/22/2012 | US20120297502 Method for improving plant tolerance to environmental stress |
11/22/2012 | US20120297500 Precise breeding - low acrylamide foods |
11/22/2012 | US20120297494 Compositions and methods of treatment of black hemophiliac patients |
11/22/2012 | US20120296072 N-terminally chemically modified protein compositions and methods |
11/22/2012 | US20120296071 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases |
11/22/2012 | US20120295990 Insulin Receptor Substrate 1 (IRS1) Protein SRM/MRM Assay |
11/22/2012 | US20120295964 Retrograde transport viral vector system having envelope comprising fused glycoprotein |
11/22/2012 | US20120295950 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity |
11/22/2012 | US20120295849 Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders |
11/22/2012 | US20120295847 Acylated GLP-1 Compounds |
11/22/2012 | US20120295837 Novel antimicrobial agents |
11/22/2012 | US20120295836 GLP-I Agonist And Cardiovascular Complications |
11/22/2012 | US20120295802 Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1 |
11/22/2012 | US20120295354 Sulfonylurea-responsive repressor proteins |
11/22/2012 | US20120295350 Prospective Identification and Characterization of Breast Cancer Stem Cells |
11/22/2012 | US20120295308 Carbohydate binding modules with reduced binding to lignin |
11/22/2012 | US20120295280 Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis |
11/22/2012 | US20120295270 Methods of using improved polymerases |
11/22/2012 | US20120295008 Production of soluble soy protein product ("s704") |
11/22/2012 | US20120294953 Surface Modified Biological Materials |
11/22/2012 | US20120294951 Use of goat serum for veterinary treatment |
11/22/2012 | US20120294924 Peptide-Lipid Conjugates And Uses Thereof |
11/22/2012 | US20120294884 Methods of blocking tissue destruction by autoreactive t cells |
11/22/2012 | US20120294883 Oligomeric receptor ligand pair member complexes |
11/22/2012 | US20120294882 Modified tuberculosis antigens |
11/22/2012 | US20120294881 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
11/22/2012 | US20120294880 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
11/22/2012 | US20120294879 Consensus sequence for influenza a virus |
11/22/2012 | US20120294878 Tlr-2 agonists and methods of use thereof |
11/22/2012 | US20120294877 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
11/22/2012 | US20120294875 Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth |
11/22/2012 | US20120294838 Regulation of endogenous gene expression in cells using zinc finger proteins |
11/22/2012 | US20120294807 Fluorescent compounds |
11/22/2012 | US20120294801 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
11/22/2012 | US20120294798 Methods of treating cancer using il-21 |
11/22/2012 | CA2836574A1 Improved peptide pharmaceuticals for insulin resistance |
11/22/2012 | CA2836288A1 Porcine reproductive and respiratory syndrome virus resistant animals |
11/22/2012 | CA2836028A1 Cytotoxic t cell inducer |
11/22/2012 | CA2835972A1 Virus-like particles and process for preparing same |
11/22/2012 | CA2835882A1 Compositions and methods for the alteration of xlhed phenotypes |
11/22/2012 | CA2835696A1 Production of soluble soy protein product ("s704") |
11/22/2012 | CA2835644A1 Pre-fusion rsv f antigens |
11/22/2012 | CA2835053A1 A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii |
11/22/2012 | CA2834678A1 Plants having one or more enhanced yield-related traits and method for making the same |
11/22/2012 | CA2834653A1 Rbm3 in bladder cancer |
11/22/2012 | CA2834183A1 Process for modifying the architecture and improving the yield of crop plants |
11/22/2012 | CA2832739A1 Novel fusion partners for the purpose of crystallizing g-protein coupled receptors |
11/21/2012 | EP2524928A1 RBM3 in bladder cancer |
11/21/2012 | EP2524927A1 New chymase binding compounds and medical uses thereof |
11/21/2012 | EP2524926A2 Anticancer peptide sequence |
11/21/2012 | EP2524697A1 Therapeutic agent for promoting recovery of animal under medical treatment |
11/21/2012 | EP2524043A1 Bacterial host strain comprising a mutant spr gene and having reduced tsp activity |
11/21/2012 | EP2524036A1 Thermostable type-a dna polymerase mutants with increased polymerization rate and resistance to inhibitors |
11/21/2012 | EP2523971A1 Therapeutic apyrase constructs, apyrase agents, and production methods |
11/21/2012 | EP2523970A1 Chimeric human beta defensins |
11/21/2012 | EP2523969A1 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity |
11/21/2012 | EP2523968A1 Cyclic peptides for the regulation of vectorial ion channels |
11/21/2012 | EP2523685A1 Variants of the group-5 allergens of the poaceae with reduced allergenicity by mutagenesis of proline residues |
11/21/2012 | EP2523684A1 Variants of the group-6 allergens of the poaceae with reduced allergenicity by mutagenesis of proline residues |
11/21/2012 | EP2523683A1 Fusion proteins for delivery of erythropoietin to the cns |